Ensign Peak Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$490K Hold
2025
Q1
$437K Buy
2024
Q4
$592K Hold
2024
Q3
$796K Hold
2024
Q2
$867K Sell
2024
Q1
$7.49M Sell
2023
Q4
$7.12M Buy
2023
Q3
$2.54M Hold
2023
Q2
$3.13M Hold
2023
Q1
$3.31M Hold
2022
Q4
$4.11M Buy
2022
Q3
$301K Hold
2022
Q2
$289K Hold
2022
Q1
$365K Hold
2021
Q4
$414K Buy